Product Program year 2025 Source: CMS Open Payments

Sephience

Drug Pku

NDC 52856-201-03

Open in the dashboard

General payments

$41,661

166 payments

Research payments

$0

0 payments

Through program year 2025, $41,661 in general payments and $0 in research payments were reported against Sephience (Pku).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $41,661 166

Breakdown

Who paid General payments · program year 2025
  1. PTC Therapeutics, Inc. $41,661 166 payments
Top recipients General payments · program year 2025
  1. Childrens Hospital Corporation Teaching hospital · MA $7,000 17% · 2 payments
  2. Janet Thomas Clinical Genetics (M.D.) · Aurora, CO $5,666 14% · 6 payments
  3. Frances Velez-Bartolomei Clinical Biochemical Genetics · San Juan, PR $3,048 7% · 2 payments
  4. Geir Ivar Elgjo Anesthesiology · Charlottesville, VA $3,000 7% · 1 payment
  5. Brittany Murray Nurse Practitioner, Family · Boston, MA $2,543 6% · 14 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nurse Practitioner, Pediatrics Nurse Practitioner $7,863 23% · 18 practitioners
  2. Clinical Genetics (M.D.) Medical Genetics $6,748 19% · 23 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $6,129 18% · 15 practitioners
  4. Physician Assistant $3,896 11% · 13 practitioners
  5. Clinical Biochemical Genetics Medical Genetics $3,284 9% · 5 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $9,739 23% · 3 recipients
  2. Colorado $5,666 14% · 1 recipient
  3. Texas $3,546 9% · 12 recipients
  4. Virginia $3,210 8% · 2 recipients
  5. Puerto Rico $3,131 8% · 2 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

166 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record